Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ProteoThera

ProteoThera
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE (Cancelled)
$5M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a bio-pharmaceutical technology designed for drug targeting. The company's tissue matrix-binding (MB) protein fusion technology improves clinical efficacy, enabling FDA approved and validated therapeutics to create a new paradigm in the treatment of autoinflammatory diseases and in tissue regeneration.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • Two Newton Executive Park
  • Suite 203, 2227 Washington Street
  • Newton, MA 02462
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ProteoThera’s full profile, request a free trial.

ProteoThera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 22-Dec-2015 $5M Cancelled Clinical Trials - Phase 1
2. Convertible Debt 01-Aug-2014 00.00 00.00 Completed Startup
1. Grant 01-Jan-2012 $1.5M Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

ProteoThera Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
RSJ Investments PE/Buyout Minority 000 0000 000000 0
Massachusetts Life Sciences Center Government 000 0000 000000 0
Partners HealthCare Innovation Corporate Venture Capital 000 0000 000000 0

ProteoThera Executive Team (6)

Name Title Board
Seat
Contact
Info
Jacques-Pierre Moreau Co-Founder, Chief Executive Officer & Board Member
Parth Patwari MD Co-Founder, Chief Scientific Officer and Board Member
Richard Lee MD Co-Founder & Chairman
Lee Simon MD Scientific Advisor
Kevin McArdle Chief Financial Officer

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

ProteoThera Board Members (4)

Name Representing Role Since Contact
Info
Jacques-Pierre Moreau ProteoThera Co-Founder, Chief Executive Officer & Board Member 000 0000
Michal Votruba RSJ Investments Board Member 000 0000
Richard Lee MD ProteoThera Co-Founder & Chairman 000 0000

1 Former Board Member

You’re viewing 3 of 4 board members. Get the full list »